Brigham and Women's Hospital: Observational study closed enrollment, 200000 enrolled (Herpes Zoster (HZ))
Brigham and Women's Hospital: Observational study closed enrollment, 200000 enrolled (Herpes Zoster (HZ)). Its enrollment of 200,000 is top-decile (99th percentile of 8,879 records). Dated 30 days ago, it is in the active follow-up window. Score 40/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 200,000 · 99th percentile of 8,879 ClinicalTrialStartPulse records · 2500.0x the median
Free preview: all 13 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | Brigham and Women's Hospital |
| Sponsor type | Academic and hospital |
| Study | Obesity and Obesity-Related Factors and Risk of Herpes Zoster (Shingles) and Postherpetic Neuralgia |
| NCT ID | NCT06638177 |
| Phase | Observational |
| Status | active not recruiting |
| Conditions | Herpes Zoster (HZ) |
| Target enrollment | 200000 |
| Posted | 2024-10-15 |
| Planned start | 1976-06 |
| Event | Enrollment closed (active, not recruiting) |
| Event date | 2026-10-05 |
| Last update posted | 2026-10-05 |
| enrollment percentile | 99th of 8,879 (median 80, 2500.0x median) |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Brigham and Women's Hospital
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock Brigham and Women's Hospital + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-05
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Brigham and Women's Hospital and 6,603 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,603
- Brigham and Women's Hospital's enrollment: 99th percentile of 8,879 records
- Timing: Medium: dated in the last 30 days
- Estimated pipeline if you contact every NONUS peer: $1,320,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
40 / 100 Score
- Enrollment closed: data management, monitoring and closeout ahead.
- 200000 participants planned.
What is the ClinicalTrialStartPulse record for Brigham and Women's Hospital?
Brigham and Women's Hospital's Observational study (NCT06638177) in Herpes Zoster (HZ), first posted 2024-10-15: enrollment closed (active, not recruiting) (2026-10-05), in an update posted 2026-10-05.
How does Brigham and Women's Hospital compare to other ClinicalTrialStartPulse records?
This is a top-decile record: its enrollment of 200,000 is 2500.0x the median of 80 across 8,879 records. It is 30 days old, still within a typical 45-day follow-up window.
Brigham and Women's Hospital vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| Brigham and Women's Hospital | NONUS | 200,000 | 99th | 2026-10-05 |
| Hoffmann-La Roche | NONUS | 1,800 | 96th | 2026-10-30 |
| Janssen Pharmaceutica N.V., Belgium | NONUS | 1,314 | 95th | 2026-11-03 |
| Janssen-Cilag International NV | NONUS | 135 | 68th | 2026-11-03 |
Related records
ClinicalTrialStartPulse: Observational ClinicalTrialStartPulse: Outside the US only
How to monitor Brigham and Women's Hospital and peer observational records
Get new ClinicalTrialStartPulse records like Brigham and Women's Hospital by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.